Cargando…
Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases
The use of nanoparticles for developing vaccines has become a routine process for researchers and pharmaceutical companies. Gold nanoparticles (GNPs) are chemical inert, have low toxicity, and are easy to modify and functionalize, making them an attractive choice for nanovaccine development. GNPs ar...
Autores principales: | Sengupta, Anirban, Azharuddin, Mohammad, Al-Otaibi, Noha, Hinkula, Jorma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030786/ https://www.ncbi.nlm.nih.gov/pubmed/35455254 http://dx.doi.org/10.3390/vaccines10040505 |
Ejemplares similares
-
Nano toolbox in immune modulation and nanovaccines
por: Azharuddin, Mohammad, et al.
Publicado: (2022) -
Sex-Specific Immune Responses to Seasonal Influenza Vaccination in Diabetic Individuals: Implications for Vaccine Efficacy
por: Sengupta, Anirban, et al.
Publicado: (2023) -
Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
por: Sengupta, Anirban, et al.
Publicado: (2022) -
Nanovaccines against Viral Infectious Diseases
por: Heng, Wen Tzuen, et al.
Publicado: (2022) -
Innate
Immune Invisible Ultrasmall Gold Nanoparticles—Framework
for Synthesis and Evaluation
por: Zhu, Geyunjian Harry, et al.
Publicado: (2021)